BioAge Labs

At BioAge Labs, our mission is to leverage the biology of human aging to develop new therapies aimed at metabolic diseases. By concentrating on targeting the molecular mechanisms behind aging, we strive to create a comprehensive pipeline of treatments that can extend the period of health in our lives, effectively increasing healthspan.

Recognizing the significant role that aging plays in many chronic conditions, our innovative approach combines extensive scientific data with a human-centric view. We utilize a proprietary human-first discovery platform that analyzes multi-omics data collected over many years, helping us to identify key pathways and molecular features that dictate how we age. Our lead program, azelaprag, has shown tremendous promise as a first-in-class oral treatment for obesity, addressing a critical health challenge of our time. As we progress, our diverse and experienced leadership team is dedicated to pushing the boundaries of science to discover and develop therapies that could redefine how we think about aging and chronic diseases.